Confirmation of lipid hypothesis in SEAS: Mortality risk stratification without lipids

3' education - July 28, 2011

Confirmation of lipid hypothesis in SEAS: Mortality risk stratification without lipids

Prof. Ingar Holme discusses the background and the main results of the SEAS trial. To further explain the outcomes of the trial, stratification by lipoprotein components and by aortic stenosis severity at baseline was performed. Prediction of the risk for ischemic events by lipid components is a valuable tool that will be further investigated.

Questions to be addressed in this PACE expert opinion are:

What is the background of the SEAS trial?
What are the main results of the SEAS trial?
Could the risk for Ischemic Cardiovascular Events (ICE) be predicted?
How should the SEAS results be implemented?
Which lipid component would be the strongest predictor?

View the expert opinion interview with prof. Holme

Click here to open the webcast in a new window

About the speaker

Professor Ingar Holme
Centre for Preventive Medicine
Ullevåll University Hospital
Oslo, Norway

Teaching slides

Confirmation of lipid hypothesis in SEAS

Mortality risk stratification without lipids

Ingar Holme, MD
Centre for Preventive Medicine
Ullevål University Hospital
Oslo, Norway
MC Lipid Innovations - May 2011

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.